28 completed, 5 unknown, 1 active not recruiting, 1 terminated. 36 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 36 | Completed 28, Unknown 5, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas Liaoning Chengda Inactivated Japanese Encephalitis Vaccine - Japanese Encephalitis | Phase 4 | Active not recruiting | Liaoning Chengda Biotechnology CO., LTD | 250 | 2024-11-14 | 2024-12-13 |
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles | Phase 4 | Completed | Liaoning Chengda Biotechnology CO., LTD | 408 | 2024-03-02 | 2025-08-28 |
| Primary TBE Vaccination for the Elderly FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine | Phase 4 | Unknown | Region Örebro County | 90 | 2024-01-01 | 2023-11-18 |
| Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients With Ventriculitis Probiotic Formula, Zinc - Ventriculitis, Infectious | Phase 4 | Completed | Ain Shams University | 140 | 2023-07-01 | 2026-10-30 |
| Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province Japanese Encephalitis Vaccine (Vero Cell), Inactivated;, No prospective interventions - Japanese Encephalitis, Vaccine Preventable Disease | Phase 4 | Unknown | Zhejiang Provincial Center for Disease Control and Prevention | 712 | 2021-03-01 | 2022-11-15 |
| Steroids in Treatment of Viral Encephalitis Methylprednisolone, Dexamethasone - Encephalitis, Viral | Phase 4 | Unknown | Assiut University | 100 | 2020-03-30 | 2020-01-29 |
| A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children Rabipur - Virus Diseases | Phase 4 | Withdrawn | GlaxoSmithKline | 2018-02-15 | 2018-02-26 | |
| Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles, mumps, rubella vaccine - Encephalitis, Japanese, Measles | Phase 4 | Completed | PATH | 628 | 2016-10-13 | 2020-10-14 |
| Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines Measles-Rubella combined vaccine(MR), Japanese Encephalitis alive vaccine(JE) - Measles, Rubella | Phase 4 | Completed | Centers for Disease Control and Prevention, China | 1043 | 2015-08-01 | 2016-08-01 |
| Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj Japanese encephalitis vaccine - Japanese Encephalitis | Phase 4 | Completed | Boryung Pharmaceutical Co., Ltd | 94 | 2015-08-01 | 2017-02-06 |
| Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine - Encephalitis, Japanese | Phase 4 | Completed | PATH | 561 | 2015-07-30 | 2020-10-19 |
| Application of a TBE-Vaccine in Obese Persons FSME-IMMUN Vaccine - Tick Borne Encephalitis | Phase 4 | Unknown | Medical University of Vienna | 73 | 2015-04-15 | 2019-09-10 |
| Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX Live attenuated chimeric Japanese Encephalitis vaccine, Inactivated Hepatitis A vaccine - Encephalitis | Phase 4 | Completed | Siriraj Hospital | 50 | 2014-06-01 | 2016-12-07 |
| Post-licensure Safety Study of IMOJEV® in Thailand IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine - Japanese Encephalitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 10000 | 2013-11-01 | 2016-05-04 |
| Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Japanese encephalitis chimeric vaccine (JECV) - Japanese Encephalitis | Phase 4 | Unknown | Khon Kaen University | 88 | 2013-10-01 | 2013-10-08 |
| Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine, Live Attenuated Varicella Vaccine, live attenuated JE vaccine - Japanese Encephalitis, Chickenpox | Phase 4 | Completed | Changchun Keygen Biological Products Co., Ltd. | 497 | 2013-03-01 | 2014-02-24 |
| Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac TicoVac - Tick-Borne Encephalitis | Phase 4 | Completed | University of Surrey | 40 | 2012-10-01 | 2018-08-03 |
| A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 Live attenuated Japanese encephalitis vaccine SA14-14-2 - Japanese Encephalitis, Japanese Encephalitis Vaccine | Phase 4 | Completed | Indian Institute of Science | 17 | 2012-05-01 | 2019-04-26 |
| Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Vaccine produced in existing facility, Vaccine produced in new facility - Japanese Encephalitis | Phase 4 | Completed | PATH | 818 | 2012-05-01 | 2018-12-05 |
| TBE Seropersistence up to 10 Years After First Booster in Adults FSME-IMMUN 0.5 ml - Tick-borne Encephalitis (TBE) | Phase 4 | Completed | Pfizer | 243 | 2012-04-01 | 2021-01-22 |
Showing 20 of 36. Sign in to see all of them.
Encephalitis, Tick-Borne (16) · Encephalitis, Japanese (15) · Measles (3) · Rubella (3) · Mumps (2) · Virus Diseases (2) · Cerebral Ventriculitis (1) · Chickenpox (1) · Encephalitis, Viral (1) · Flavivirus Infections (1) · Hepatitis (1) · Immune Reconstitution Inflammatory Syndrome (1) · Leukoencephalopathy, Progressive Multifocal (1) · Rabies (1)
Brain Diseases (36) · Central Nervous System Diseases (36) · Nervous System Diseases (36) · Neuroinflammatory Diseases (36) · Infections (35) · Central Nervous System Infections (34) · Central Nervous System Viral Diseases (34) · Infectious Encephalitis (33) · Encephalitis, Viral (32) · RNA Virus Infections (32) · Virus Diseases (32) · Arbovirus Infections (31) · Encephalitis, Arbovirus (31) · Flaviviridae Infections (31)
Vaccines (3) · Blood Specimen Collection (2) · FSME-IMMUN vaccine (2) · Japanese Encephalitis Vaccines (2) · Measles-Mumps-Rubella Vaccine (2) · Methylprednisolone (2) · Prednisolone (2) · Dexamethasone (1) · Hepatitis A Vaccines (1) · Influenza Vaccines (1) · Lacteol (1) · Methylprednisolone Hemisuccinate (1) · Rabies Vaccines (1) · Zinc (1) · Zinc Sulfate (1)
Pfizer (7) · PATH (5) · Novartis (3) · GlaxoSmithKline (2) · Liaoning Chengda Biotechnology CO., LTD (2) · Medical University of Vienna (2) · Ain Shams University (1) · Assiut University (1) · Biogen (1) · Boryung Pharmaceutical Co., Ltd (1) · Centers for Disease Control and Prevention, China (1) · Changchun Keygen Biological Products Co., Ltd. (1) · Indian Institute of Science (1) · Khon Kaen University (1) · Novartis Vaccines (1)
Germany (8) · Austria (5) · China (5) · Poland (5) · Belgium (2) · Sri Lanka (2) · Thailand (2) · Bangladesh (1) · Czechia (1) · Egypt (1) · India (1) · Philippines (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Nihal Abeysinghe, MD, MSc (2) · Ryszard Konior, MD (2) · Ursula Wiedermann-Schmidt, MD, PhD (2) · David JM Lewis (1) · Dr V Ravi, MBBS MD (1) · HJ Jung, MD (1) · Huanyu Wang (1) · Huaqing Wang, MD, PhD (1)
PMID 21592984, PMID 28545923, PMID 25239483, PMID 25728316, PMID 27846060, PMID 27903416, PMID 28135273, PMID 29429815, PMID 30833160, PMID 30928173, PMID 32528467, PMID 35243320
2009 (1)